Walleye Trading
PLRX icon

Walleye Trading’s Pliant Therapeutics PLRX Stock Holding History

Walleye Trading’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,064
Closed -$215K – 5082
2023
Q1 		$215K Buy
+8,064
New +$230K ﹤0.01% 3456
2022
Q4 		– Sell
-11,280
Closed -$236K – 5299
2022
Q3 		$236K Buy
+11,280
New +$216K ﹤0.01% 3546

Other funds holding PLRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Walleye Trading's PLRX Position: Q2 2023 in Review

Walleye Trading sold out of Pliant Therapeutics (PLRX) in Q2 2023, closing a stake of 8,064 shares — an estimated $215K sold.

Walleye Trading first reported a position in PLRX in Q3 2022 and held it in 2 quarters. The position peaked at $236K in Q3 2022. 144 funds tracked by Wall St. Rank hold PLRX as of Q2 2023.

  • Walleye Trading reported no remaining Pliant Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 8,064 Pliant Therapeutics shares in Q2 2023, an estimated $215K.
  • Walleye Trading first reported a position in Pliant Therapeutics in Q3 2022 and held it in 2 quarters.
  • Walleye Trading's Pliant Therapeutics position peaked at $236K in Q3 2022.
  • 144 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.